KP Tissue Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	50.73	8.5	2.43	-4.94	-10.25	1.24
Depreciation & Amortization	63.81	-	-	-	-	-
Other Adjustments	56.35	-17.01	-4.87	9.87	20.5	-2.48
Changes in Other Operating Activities	57.44	-	0	0	0	0
Operating Cash Flow	237.35	-8.5	-2.43	4.94	10.25	-1.24
Operating Cash Flow Growth	88.72%	-	-	-51.83%	-	-
Capital Expenditures	-45.75	-	-	-	-	-
Purchases of Intangible Assets	-3.89	-	-	-	-	-
Other Investing Activities	7.92	6.96	6.97	6.98	6.62	5.56
Investing Cash Flow	6.95	6.96	6.97	6.98	6.62	5.56
Long-Term Debt Issued	142.98	-	-	-	-	-
Long-Term Debt Repaid	-183.13	-	-	-	-	-
Net Long-Term Debt Issued (Repaid)	-40.15	-	-	-	-	-
Common Dividends Paid	-6.95	-6.96	-6.97	-6.98	-6.62	-5.56
Other Financing Activities	-21.48	-	-	-	-	-
Financing Cash Flow	-6.95	-6.96	-6.97	-6.98	-6.62	-5.56
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.27	-	-	-	-	-
Net Cash Flow	63.82	-8.5	-2.43	4.94	10.25	-1.24
Free Cash Flow	191.6	-8.5	-2.43	4.94	10.25	-1.24
Free Cash Flow Growth	-	-	-	-51.83%	-	-
FCF Margin	34.21%	-	-	-	-	-
Free Cash Flow Per Share	19.14	-0.85	-0.24	0.50	1.03	-0.13
Levered Free Cash Flow	44.29	8.5	2.43	-4.94	-10.25	1.24
Unlevered Free Cash Flow	115.67	0	0	0	0	0